Frankfurt - Delayed Quote EUR
Viking Therapeutics, Inc. (1VT.F)
22.01
+0.18
+(0.85%)
As of 8:06:17 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FOEHR MATTHEW W Director | Conversion of Exercise of derivative security | Apr 11, 2025 | 132,036 |
| LIAN BRIAN Chief Executive Officer | Sale | Jan 6, 2025 | 2,366,570 |
| MACARTNEY LAWSON Director | Sale | Nov 8, 2024 | 47,965 |
| MANCINI MARIANNA Chief Operating Officer | Sale | Jan 6, 2025 | 374,134 |
| ROUAN SARAH KATHRYN Director | Purchase | Mar 31, 2025 | 1,240 |
| ROWLAND CHARLES A JR Director | Sale | May 16, 2023 | 30,000 |
| SINGLETON J MATTHEW Director | Sale | Oct 25, 2024 | 9,500 |
| ZANTE GREGORY S Chief Financial Officer | Sale | Jan 6, 2025 | 165,259 |
Related Tickers
PI3.DU Gubra AS
46.92
-2.70%
LYTIX.OL Lytix Biopharma AS
5.18
-3.72%
ASMB Assembly Biosciences, Inc.
10.68
+2.61%
SPRB Spruce Biosciences, Inc.
0.1322
-0.53%
PTCT PTC Therapeutics, Inc.
49.96
+0.01%
LCTX Lineage Cell Therapeutics, Inc.
0.4616
-2.20%
VNDA Vanda Pharmaceuticals Inc.
4.3391
+0.21%
GRCE Grace Therapeutics, Inc.
2.2983
+0.37%
CANF Can-Fite BioPharma Ltd.
1.1950
+1.27%
TSHA Taysha Gene Therapies, Inc.
1.8000
-1.10%